Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04335136
Brief Title: Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 (APN01-COVID-19)

First Submitted : April 1, 2020
First Submitted that Met QC Criteria : April 3, 2020
First Posted : April 6, 2020

Results First Submitted : June 7, 2021
Results First Posted with QC Comments : June 14, 2021
Results First Submitted that Met QC Criteria : July 29, 2021
Results First Posted : August 2, 2021

Last Update Submitted that Met QC Criteria : July 29, 2021
Last Update Posted : August 2, 2021